Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors Dealings

15 Dec 2016 07:00

RNS Number : 8950R
Ubisense Group PLC
15 December 2016
 

15 December 2016

Ubisense Group plc

("Ubisense" or the "Company")

Directors Dealings and Adoption of a new Long Term Incentive and Share Option Plan

Ubisense Group plc (AIM: UBI) announces the adoption of a new Long Term Incentive and Share Option Plan ("LTISOP") and the grant of share awards to the Executive Directors under the LTISOP.

Background

The Company has recently completed through its Remuneration Committee a full review of its incentive arrangements supported by independent external advice, noting that no further awards were possible under the existing share option schemes. As a result of this review the Remuneration Committee has adopted a new 5 year LTISOP for its Executive Directors and other senior management members. The Remuneration Committee believes that the new LTISOP will encourage strong and sustained corporate performance in order to drive returns to shareholders over the longer-term. Furthermore, it will allow participants to build up a meaningful shareholding in the Company, hence helping to ensure that their interests are closely aligned with those of shareholders. Furthermore, the Remuneration Committee is satisfied that the composition and structure of the remuneration package is appropriate and does not incentivise undue risk-taking or reward underperformance.

Structure of the new LTISOP

An award of nominal cost options will be granted to the Executive Directors and a small number of other senior management staff. Performance conditions will be attached to all nominal-cost options requiring the Company's share price to exceed 70p for 60 consecutive calendar days between the 2nd and 3rd anniversary of issue for the shares to vest. Vested shares may be exercised after the 4th anniversary of issue. Recipients must remain an employee or director of the Company at the time of vesting. The LTISOP includes terms such that in the event of a takeover or business unit disposal delivering above target results then vesting and the ability to exercise the awards are accelerated for those recipients whose employment or directorship is impacted.

The maximum number of nominal cost options to be awarded will be 5,600,000.

Annual awards in the form of market value options may also be granted to the Executive Directors and senior management in future periods. Standard vesting terms are annual over 3 years and without performance conditions although the Remuneration Committee has the ability to vary these terms. The maximum number of market value options to be awarded will be limited to 5% of the issued share capital over the 5 year life of the LTISOP.

Awards under the LTISOP

On 14 December 2016, the following nominal cost option awards were made under the LTISOP:

Name

Position

Number of nominal cost option awards granted

Total of all outstanding options including new LTISOP award

Peter Harverson

Executive Chairman

850,000

941,333

Richard Petti

Chief Executive Officer

1,600,000

1,600,000

Tim Gingell

Chief Financial Officer

700,000

700,000

 

Following the awards above and the other awards to the senior management team, the number of outstanding nominal cost options is 5,600,000. Outstanding options awarded to certain employees in prior years under the existing share option scheme are 1,003,472, which have exercise prices between 14p and 225p, details of which were included in the 2015 Annual Report.

The awards to Directors under the LTISOP fall to be treated as a related party transaction under the AIM Rules for Companies. With the exception of those directors who are involved in the transaction as related parties, the Company's directors consider, having consulted with Numis Securities Limited its nominated adviser, that the terms of the transaction are fair and reasonable insofar as its shareholders are concerned.

 

 

For further information contact:

 

Ubisense Group plc +44 (0)1223 535170

Peter Harverson

Richard Petti

Tim Gingell

 

Numis Securities Limited  +44 (0)20 7260 1000

Simon Willis

Jamie Lillywhite

Toby Adcock

 

Redleaf Communications   +44 (0)20 7382 4730

Rebecca Sanders-Hewett

David Ison

 

 

About Ubisense

 

Ubisense (AIM: UBI), a global leader in Enterprise Location Intelligence solutions, helps manufacturing, communications and utility companies improve operational efficiency and boost profitability. Ubisense location intelligence systems bring clarity to complexity, enabling customers to revolutionise their operational effectiveness in a measurable way. Founded in 2002, Ubisense is headquartered in Cambridge, England, with offices in North America, France, Germany and Japan. For more information visit: www.ubisense.net.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDBBDDRUBBGLS
Date   Source Headline
11th Apr 202311:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSFinal Results
17th Mar 20234:30 pmRNSNotice of Results and Investor Presentation
23rd Feb 202310:15 amRNSDirector/PDMR Shareholding
20th Feb 202311:45 amRNSDirector/PDMR Shareholding
15th Feb 20235:45 pmRNSExercise of Options and Total Voting Rights
15th Feb 20237:00 amRNSIQGeo Signs Strategic Contract in Japan
9th Feb 20237:00 amRNSFollow on contract with global telecom operator
6th Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 202310:31 amRNSHolding(s) in Company
19th Jan 20236:00 pmRNSExercise of Options and Total Voting Rights
12th Jan 20237:00 amRNSTrading update
8th Dec 202210:00 amRNSExercise of Options and Total Voting Rights
6th Dec 20226:00 pmRNSDirector/PDMR Shareholding
24th Nov 20223:00 pmRNSHolding(s) in Company
23rd Nov 20225:15 pmRNSHolding(s) in Company
21st Nov 202210:15 amRNSDirector/PDMR Shareholding
7th Nov 202210:15 amRNSDirector/PDMR Shareholding
31st Oct 202212:00 pmRNSDirector/PDMR Shareholding
13th Oct 20228:30 amRNSExercise of Options and Total Voting Rights
10th Oct 20227:00 amRNSDirector/PDMR Shareholding - Grant of Options
6th Oct 20227:00 amRNSContract wins for IQGeo and Comsof software
20th Sep 20227:00 amRNSHalf-year Report
30th Aug 20221:49 pmRNSHolding(s) in Company
25th Aug 202210:30 amRNSNotice of Interim Results & Investor Presentation
23rd Aug 20227:00 amRNSHolding(s) in Company
19th Aug 202212:00 pmRNSHolding(s) in Company
17th Aug 20221:30 pmRNSDirector/PDMR Shareholding
17th Aug 202212:30 pmRNSHolding(s) in Company
12th Aug 20221:30 pmRNSResults of Fundraising and Total Voting Rights
12th Aug 20227:00 amRNSAcquisition and Placing to Raise c.£3.5m
14th Jul 20227:00 amRNSTrading Update
4th Jul 20227:00 amRNSGlobal top 5 telecom operator selects IQGeo
6th Jun 20223:15 pmRNSHolding(s) in Company
6th Jun 20223:00 pmRNSExercise of Options and Total Voting Rights
17th May 20223:13 pmRNSResult of AGM
9th May 20227:00 amRNSEarn Out Consideration and Total Voting Rights
3rd May 202212:15 pmRNSDirector/PDMR Shareholding
25th Apr 202211:00 amRNSDirector/PDMR Shareholding
14th Apr 20227:00 amRNSPosting of the Annual Report and Notice of AGM
1st Apr 20225:46 pmRNSDirector/PDMR Shareholding
24th Mar 20225:45 pmRNSHolding(s) in Company
23rd Mar 20225:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20225:43 pmRNSDirector/PDMR Shareholding - Replacement
22nd Mar 20227:00 amRNSFinal Results
2nd Mar 20222:45 pmRNSNotice of Results and Investor Presentation
21st Feb 20221:15 pmRNSDirector/PDMR Shareholding
8th Feb 20223:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.